Chemoradiotherapy With Targeted Immunotherapy in Pediatric Lymphoma
Clinical trial NCT05253495 · RECRUITING
Trial details
- NCT number
- NCT05253495
- Sponsor
- New York Medical College
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-01
- Primary completion
- 2027-12-31
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.